We can’t wait another 100 years to End Diabetes

    NEXT STORY
    Cytokinetics Announces First Patient Dosed in Cohort 2 of Redwood-HCM
    PREV STORY
    Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    eGenesis Appoints Veteran Biotechnology Development Executive, Michael Curtis, Ph.D., as President of Research & Development

    author_avatar
    NASDAQ Market News

    Auris Medical Completes Enrollment of TACTT2 Phase 3 Trial of AM-101 in Acute Inner Ear Tinnitus

    Basel, Switzerland, March 30, 2016 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (NASDAQ:EARS), a ...

    author_avatar
    NASDAQ Market News

    Trevena announces completion of leadership transition and appointment of new director

    – Carrie Bourdow assumes CEO position and joins Board of Directors – – Maxine ...

    author_avatar
    NASDAQ Market News